Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

NCT00002494 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2016-07-04

No results posted yet for this study

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells.

PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy and alternating regimens of chemotherapy in treating patients who have non-Hodgkin's lymphoma or acute lymphocytic leukemia.

Conditions

Interventions

DRUG: cyclophosphamide
DRUG: cytarabine
DRUG: dexamethasone
DRUG: doxorubicin hydrochloride
DRUG: etoposide
DRUG: ifosfamide
DRUG: leucovorin calcium
DRUG: mesna
DRUG: methotrexate
DRUG: prednisone
DRUG: therapeutic hydrocortisone
DRUG: vincristine sulfate
RADIATION: low-LET cobalt-60 gamma ray therapy
RADIATION: low-LET photon therapy

Sponsors & Collaborators

National Cancer Institute (NCI)
collaborator NIH
Alliance for Clinical Trials in Oncology
lead OTHER

Principal Investigators

Edward Lee, MD · Central Maryland Oncology Center

Study Design

Allocation: NA
Purpose: TREATMENT
Masking: NONE
Model: SINGLE_GROUP

Eligibility

Min Age: 15 Years
Sex: ALL
Healthy Volunteers: No

Timeline & Regulatory

Start: 1992-05-31
Primary Completion: 2004-03-31
Completion: 2006-01-31

Countries

United States

Study Locations

More Related Trials

Entities

Drugs

Diseases